Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FXNF3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,325
Award facts
- Contract value 100% obligated
- $11,324.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,324.83 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) on September 29, 2025, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected to fulfill this pharmaceutical supply requirement for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The DLA Troop Support Medical leverages such contracts to ensure consistent pharmaceutical availability across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with Vraylar—a neurological treatment medication—representing one of many critical therapeutic products supplied through this arrangement.
Quick answers
Who was awarded contract SPE2DB25FXNF3?
SPE2DB25FXNF3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FXNF3 worth?
The government has obligated $11,325 on SPE2DB25FXNF3.
Is contract SPE2DB25FXNF3 an order under another contract?
Yes. SPE2DB25FXNF3 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXNF3 competed?
The extent of competition for SPE2DB25FXNF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award